AzTrials
AzTrials

CABGNCT05285865

Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients

A study testing Conventional Treatment and Scapular Mobilization in people with CABG, run by Riphah International University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To determine the effects of scapular mobilization on pulmonary functions of post-CABG patients. Read more about this study

Who is it for?
Ages 40 to 70 years
Conditions the study is for
CABG
What is being tested?
Conventional Treatment and Scapular Mobilization
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 sitePakistan
Study dates
15 Mar 2022to 1 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • CAD patients undergone CABG surgery (Post-Op. Day#. 01).
  • Both genders (male and female).
  • Aged between 40 to 70 years .
  • Patient having oxygen saturation (SPO2) of more than or equal to 90% with 25% of fraction of inspired oxygen (FiO2) - (possibly nasal cannula inserted).

Who cannot join

  • Patients with low glasgow coma scale (GCS) score (less than 15).
  • Patients having inspiratory capacity of 3500ml and above.
  • Patients on ventilator.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Rehman Medical Institute

    Peshawar, KPK, 46000

Other trials in Pakistan

About this study

Official title: Effects of Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients

To determine the effects of scapular mobilization on pulmonary functions of post-CABG patients.

Conditions
CABG
Being tested
Conventional Treatment, Scapular Mobilization

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional TreatmentOther

    Thrice a day for complete length of stay. This is Conventional treatment The total duration of session will be of 15-20 mins.

  • Scapular MobilizationOther

    Thrice a day for complete length of stay including two sets of repetitions with a rest interval of 30 seconds between sets. Grade 1-3 As reported in a study Scapular mobilization (SM) i.e., Scapular superior, inferior glides, upward and downward rotations and scapular distraction, along with Conventional treatment according to American Heart Association Guidelines i.e., Incentive spirometer, chest clearance, expectoration of the sputum (suctioning if needed), mobilizing the patient out of bed, AAROM and AROM exercises.

Study groups in NCT05285865
Study groupRoleWhat they receive
Conventional TreatmentActive comparatorThrice a day ,Conventional treatment according to American Heart Association Guidelines i.e., Incentive spirometer, chest clearance, expectoration of the sputum (suctioning if needed), mobilizing the patient out of bed, AAROM and AROM exercises.
Receives: Other: Conventional Treatment
Scapular MobilizationExperimentalThrice a day Scapular mobilization (SM) along with Conventional treatment
Receives: Other: Scapular Mobilization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incentive Spirometer

    An incentive spirometer is a device that will expand the lungs by helping the patient breathe more deeply and fully

    Measured: 1 week

  2. Borg scale

    The Borg Rating of Perceived Exertion (RPE) is a way of measuring physical activity intensity level.

    Measured: 1 week

  3. Numeric pain rating scale

    What is a numerical pain rating scale? The Numerical Pain Rating Scale (NPRS) is a subjective measure in which individuals rate their pain

    Measured: 1 week

  4. Digital Spirometer

    Spirometer is a portable lung function testing device, which mainly used to examine lung function related parameters for patients

    Measured: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2022
  2. Study start15 Mar 2022
  3. Primary completion10 Feb 2023
  4. Study completion1 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05285865
Sponsor's protocol ID
REC/01278 Sakina Asghar
Status last verified
Aug 2023
First submitted
8 Mar 2022
Last updated
1 Sep 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Conventional Treatment and Scapular Mobilization in people with CABG, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incentive Spirometer (time frame: 1 week). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in